Shares plunged nearly 49% on February 12 following the company's announcement of delayed Q4 and full-year 2025 earnings due to an Audit Committee investigation into revenue recognition practices for 2023-2025. Preliminary findings indicated revenue overstated by under 2% for 2023 and 2024, with no customer impact noted, though full-year 2025 guidance was withdrawn and material control weaknesses expected. Today's 13.04% gain reflects traders viewing the prior drop as excessive relative to the quantified immaterial issue, supported by elevated volume signaling accumulation.
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.